IP Library Granted Patent US 8,524,500
Granted Patent B2
US 8,524,500 · App. 12/804,234 · Granted Sep 3, 2013

Methods and compositions for targeted cleavage and recombination

Inventors: Fyodor Urnov (Richmond, CA); Michael C. Holmes (Oakland, CA); Jeffrey C. Miller (San Francisco, CA); Carl O. Pabo (Mill Valley, CA)
Assignee: Sangamo BioSciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,500
App. No.
12/804,234
Granted
Sep 3, 2013
Kind
B2
Abstract

Disclosed herein are methods and compositions for targeted cleavage of a genomic sequence, targeted alteration of a genomic sequence, and targeted recombination between a genomic region and an exogenous polynucleotide homologous to the genomic region. The compositions include fusion proteins comprising a cleavage domain (or cleavage half-domain) and an engineered zinc finger domain and polynucleotides encoding same. Methods for targeted cleavage include introduction of such fusion proteins, or polynucleotides encoding same, into a cell. Methods for targeted recombination additionally include introduction of an exogenous polynucleotide homologous to a genomic region into cells comprising the disclosed fusion proteins.

Claims (15)

1. A method of targeted mutation of a non-coding sequence in a region of interest in cellular chromatin in an isolated plant or mammalian cell containing a region of interest in cellular chromatin, the method comprising:

(a) selecting first and second nucleotide sequences in the region of interest;

(b) engineering first and second zinc finger binding domains to bind to the first and second nucleotide sequences;

(c) expressing a first fusion protein in the isolated cell, the first fusion protein comprising the first engineered zinc finger binding domain and a first FokI cleavage half-domain; and

(d) expressing a second fusion protein in the cell, the second fusion protein comprising the second zinc finger binding domain and a second FokI cleavage half-domain

wherein the first and second fusion proteins cleave cellular chromatin and mutate the non-coding sequence in the region of interest and further wherein one of the cleavage half-domains comprises an alteration in amino acid 490 of the wild-type dimerization interface of the cleavage half-domain.

2. The method of claim 1 , wherein cleavage occurs between the first and second nucleotide sequences.

3. The method of claim 1 , wherein non-coding sequences in the region of interest are deleted.

4. The method of claim 1 , wherein the mutation is selected from the group consisting of one or more nucleotide substitutions, one or more nucleotide deletions and one or more nucleotide insertions.

5. The method of claim 1 , wherein the non-coding sequence is a transcriptional regulatory sequence.

6. The method of claim 1 , wherein the first and second fusion proteins are expressed from different polynucleotides.

7. The method of claim 1 , wherein the first and second fusion proteins are expressed from a single polynucleotide.

8. A method of introducing an exogenous sequence into a non-coding region of interest of cellular chromatin of an isolated plant or mammalian cell, the method comprising,

mutating the non-coding sequence in the cell according to the method of claim 1 ; and

introducing a polynucleotide comprising the exogenous sequence into the cell, such that when the cellular chromatin is cleaved in the cell, the exogenous sequence is integrated into the non-coding region of interest.

Assignments (1)
CHANGE OF NAME Recorded May 19, 2017
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 042506/0290 →
Continuity (8)
Continuation 10912932 · Aug 6, 2004
Provisional Application 60493931 · Aug 8, 2003
Provisional Application 60518253 · Nov 7, 2003
Provisional Application 60530541 · Dec 18, 2003
Provisional Application 60542780 · Feb 5, 2004
Provisional Application 60556831 · Mar 26, 2004
Provisional Application 60575919 · Jun 1, 2004
Related Publication 20110030076A1 · Feb 3, 2011